Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 31.15
+0.05 (0.16%)
Dec 19, 2025, 1:35 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 23.96 billion as of December 19, 2025. Its market cap has decreased by -39.87% in one year.
Market Cap
23.96B
Enterprise Value
26.31B
Revenue
70.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.15
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 23.96B, a decrease of -48.42%. That is a compound annual growth rate of -6.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 24.00B | -29.54% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | 11.20B | -8.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 234.19B |
| PharmaEssentia | 183.26B |
| Heron Neutron Medical | 82.78B |
| Lotus Pharmaceutical | 74.16B |
| Bora Pharmaceuticals Co., LTD. | 60.97B |
| Lin BioScience | 33.26B |
| Lumosa Therapeutics | 31.33B |
| Center Laboratories | 28.22B |